Le Lézard
Classified in: Health, Covid-19 virus
Subjects: NPT, LEG, AVO

An Emergency Lecture Series on Bill C-7 and Palliative Care


TORONTO, Feb. 18, 2021 /CNW/ - The deVeber Institute presents a two-day Emergency Lecture Series on Bill C-7 and Palliative Care via Zoom Webinar on Tuesday, February 23 and Wednesday, February 24 at 7pm (ET).

The deVeber Institute is honoured to host seven eminent speakers at this crucial juncture in Canadian law, medicine, and society. In the midst of the Covid-19 pandemic, Parliament and the Senate are hastening towards a total rewrite of medical assistance in dying.

Legal and medical experts are joining the deVeber Institute to warn of these potential changes from their frontline, first-hand experiences.

Have they been listened to?

What do leaders in palliative care know about assisted suicide's impact on patient care?

Why have over 800 physicians signed the MAiD to MAD declaration?

The presenters include:

Dr. Ramona Coelho (A family physician in London, ON):
Conscientious objections, what will happen to the doctors who do not agree that administered death is good medicine?

Dr. Leonie Herx (The head of Palliative Medicine at Queen's University):
The palliative care perspective: How will Bill C7 impact end of life care?

Dr. Thomas Bouchard (A family physician in long-term care in Calgary, AB):
Why we need ethical safeguards for the vulnerable

Dr. Sephora Tang (A psychiatrist in Ottawa, ON):
The need to improve assisted living prior to assisted death; a psychiatrist's perspective

Bob Parke (A bioethicist in Toronto, ON):
The palliative care philosophy and the importance of early engagement

Dr. Jaro Kotalik (Professor at the Northern Ontario School of Medicine, Lakehead University):
Why we need more accurate monitoring and reporting of MAiD statistics

Dylan McGuinty Jr (Lawyer in Ottawa, ON):
Proposed changes to Assisted Dying in Canada; a lawyer's perspective

Join the deVeber Institute on Tuesday, February 23 and Wednesday, February 24 at 7pm (ET) via Zoom Webinar to hear from these experts.

To register for February 23rd with presentations from Dr. Coelho, Dr. Herx, and Dr. Bouchard:
https://us02web.zoom.us/webinar/register/WN_JOJaAmojQ9m5xvRSL9hNew

To register for February 24th with presentations from Dr. Tang, Mr. Parke, Dr. Kotalik, and Mr. McGuinty Jr:
https://us02web.zoom.us/webinar/register/WN_3XWjH2XpQx6J01Pb6FufbQ

For additional information, contact the deVeber Institute at [email protected].

SOURCE deVeber Institute for Bioethics and Social Research


These press releases may also interest you

at 20:40
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

at 19:40
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

at 19:05
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

at 19:00
David J. Dykeman, co-chair of the Life Sciences & Medical...

at 18:30
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community.  Aspire Health experienced a data security incident that may have involved personal and...

at 17:21
Chemistree Technology Inc. (US OTC: CHMJF) (the "Company" or "Chemistree"), is pleased to announce that the adjourned extraordinary meeting of the holders of the 10% senior unsecured convertible debentures of the Company (the "Debentures") was...



News published on and distributed by: